These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 8461566

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M, Saraf ML.
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of nandrolone decanoate on bone mass in established osteoporosis.
    Passeri M, Pedrazzoni M, Pioli G, Butturini L, Ruys AH, Cortenraad MG.
    Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cross-over study of fat-corrected forearm mineral content during nandrolone decanoate therapy for osteoporosis.
    Need AG, Horowitz M, Walker CJ, Chatterton BE, Chapman IC, Nordin BE.
    Bone; 1989 Nov; 10(1):3-6. PubMed ID: 2736154
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C, AgnusDei D, Gonnelli S, Nardi P.
    Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
    [Abstract] [Full Text] [Related]

  • 9. [Prophylaxis and treatment of osteoporosis].
    Kopera H.
    Klin Wochenschr; 1989 May 15; 67(10):557-8. PubMed ID: 2739351
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year.
    Gerritsma EJ, Brocaar MP, Hakkesteegt MM, Birkenhäger JC.
    Clin Otolaryngol Allied Sci; 1994 Feb 15; 19(1):79-84. PubMed ID: 8174308
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effects on the bones of nandrolone decanoate therapy in postmenopausal osteoporosis].
    Gennari C, Agnusdei D, Gonnelli S.
    Minerva Endocrinol; 1989 Feb 15; 14(1):69-74. PubMed ID: 2659955
    [Abstract] [Full Text] [Related]

  • 15. The androgenic anabolic steroid nandrolone decanoate prevents osteopenia and inhibits bone turnover in ovariectomized cynomolgus monkeys.
    Jerome CP, Power RA, Obasanjo IO, Register TC, Guidry M, Carlson CS, Weaver DS.
    Bone; 1997 Apr 15; 20(4):355-64. PubMed ID: 9108356
    [Abstract] [Full Text] [Related]

  • 16. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S, Rossini M.
    Wien Med Wochenschr; 1993 Apr 15; 143(14-15):395-7. PubMed ID: 8256456
    [Abstract] [Full Text] [Related]

  • 17. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
    Johansen KL, Mulligan K, Schambelan M.
    JAMA; 1999 Apr 14; 281(14):1275-81. PubMed ID: 10208142
    [Abstract] [Full Text] [Related]

  • 18. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
    Hassager C, Jensen LT, Pødenphant J, Thomsen K, Christiansen C.
    Calcif Tissue Int; 1994 Jan 14; 54(1):30-3. PubMed ID: 8118750
    [Abstract] [Full Text] [Related]

  • 19. Effect of nandrolone decanoate on the lipid profile of male peritoneal dialysis patients.
    Mora C, Macía ML, García J, Navarro JF.
    Perit Dial Int; 2001 Jan 14; 21(6):611-4. PubMed ID: 11783772
    [No Abstract] [Full Text] [Related]

  • 20. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A, Barbieri T, Neese R, Van Loan M, Christiansen M, Hoh R, Sathyan G, Skowronski R, King J, Hellerstein M.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb 01; 20(2):137-46. PubMed ID: 10048900
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.